LUANN DEAFENBAUGH: Open Payments
NPI 1003058454 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,247 in 63 payments from 20 companies in 2025. Trend: 2023 $975 · 2024 $778 · 2025 $1,247
Food & beverage: $1,247
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 13 | $271 |
| Novartis Pharmaceuticals Corporation | 8 | $172 |
| AstraZeneca Pharmaceuticals LP | 6 | $124 |
| Eisai Inc. | 5 | $99 |
| Janssen Biotech, Inc. | 4 | $82 |
| Adaptive Biotechnologies Corporation | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| ABBVIE INC. | 3 | $57 |
| GENZYME CORPORATION | 2 | $38 |
Products named: KEYTRUDA, KISQALI, Lenvima, Enhertu, clonoSEQ, OPDIVO, RYBREVANT, PLUVICTO.
Industry payments across IN — which companies pay providers there.
